Emmanuel Macron announces 16 new biomedical research centers

New announcements for health. Emmanuel Macron unveiled, Tuesday, May 16, a list of 16 new biomedical research centers in France, co-financed by public and private funds. They are part of the section of the 2030 Health Innovation plan aimed at strengthening France’s international attractiveness in this area. “The time has come to work towards a more unified, better endowed biomedical research”, underlined the President of the Republic during a visit to the premises of the Institut Curie in Saint-Cloud.

Emmanuel Macron announced the labeling of 12 new university hospital institutes (IHU), in addition to the seven already existing. He also unveiled four new “bioclusters”, major research sites combining public and private sectors, which will be added to a first cancerology biocluster created in recent years in Saclay (Essonne). These newly certified centers of excellence, which will receive financial support from the State, are scattered across France, from Villejuif (Val-de-Marne) to Bordeaux, via Garches (Hauts-de- Seine), Lyons or Marseilles. Institut Curie is notably on the list of winning IHUs.

More than “400 million euros” for bioclusters

The Health Innovation 2030 plan is a variation of the France 2030 plan. The latter has a total budget of 7.5 billion euros. Of this amount, more than a billion must be devoted to research, and other programs of excellence must be launched soon, said Emmanuel Macron.

In detail, the State plans to devote “more than 400 million euros” bioclusters, already funded by industry, and some 300 million for IHUs. Must be added 100 million to particularly strengthen the biology infrastructure through various projects funded in France. State investments must be supplemented by funding from local authorities and private actors.